# Jade Biosciences, Inc.: Form SCHEDULE 13D/A, filed Apr 30, 2025

- Company: [Jade Biosciences, Inc.](/companies/jbio.md) (CIK 1798749)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:29 ET
- Period: not reported
- Accession: 0001415889-25-011576
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1798749/000141588925011576/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1798749/000141588925011576/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1798749/000141588925011576/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-011576. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.